OSSIS Becomes a Part of Zimmer Biomet
On 1st May 2023, Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, announced a definitive agreement to acquire OSSIS.
The acquisition follows a successful partnership that began in APAC in July 2021 with an agreement between ZB and OSSIS for patient-specific 3D-printed titanium hip joint replacements and other pelvic bone replacement surgery. From there, the exclusive distributor agreement was expanded to EMEA at the end of last year.
“Combining OSSIS' more than 16 years’ clinical experience and engineering expertise with Zimmer Biomet's extensive network across Asia Pacific, Europe, Middle East and Africa demonstrates our commitment to bring transformative med tech advancements to patients in need,” said Sang Yi, Zimmer Biomet Asia Pacific Group President. “We are very pleased to partner with these patients and their physicians as we work toward our mission to alleviate pain and improve the quality of life for people around the world.”
"Zimmer Biomet shares our ethos of innovative technology with a strong patient focus, and OSSIS is thrilled to join Zimmer Biomet's established portfolio with cutting-edge solutions and expert capabilities," said Kelvin Hyland, OSSIS Managing Director.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit zimmerbiomet.com or follow Zimmer Biomet on X at x.com/zimmerbiomet
For more information about our solutions, talk with the team.
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.
OSSIS designs and manufactures custom-made implants which are used by surgeons to treat patients with unique clinical needs that cannot be effectively treated with off-the-shelf products. As each OSSIS implant is unique to the patient, mechanical testing and engineering data and clinical test results are often unavailable for such devices. Consequently, the mechanical integrity of such devices cannot be validated. Surgeons should consider these issues and inform their patients about the additional risks associated with custom-made implants. For product information, including indications, contraindications, warnings, precautions and potential adverse effects, see Instructions for Use or contact OSSIS.